Found 4 Cytomegalovirus Infections trials

A listing of Cytomegalovirus Infections medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Clinical Performance of the Aptima CMV Quant Assay on the Panther System

99 years or below

All genders

The purpose of this study is to look at the effectiveness of an investigational test called the Aptima CMV Quantification Diagnostic Assay (Aptima CMV Quant Assay) to measure levels of CMV in plasma. The target population is subjects who have tested positive for cytomegalovirus (CMV) after receiving a solid-organ transplant …

Learn More

UPCC 38422: Phase 3 Multicenter Double-Blind Placebo-Controlled Trial of Viralym-M (ALVR105) for the Treatment of Patients With Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplant

99 years or below

All genders

A study to evaluate posoleucel (ALVR105); an allogeneic, off-the-shelf multi-virus specific T cell therapy that targets six viral pathogens: BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6 and JC virus. We would like to rely on WCG as the IRB of record for this study.

Learn More

Evaluating an Investigative Drug Letermovir (Prevymis) in Adults with Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV)

40 years - 99 years

All genders

Interventional

The purpose of this study is to test letermovir when given to people who have both well-controlled HIV infection and asymptomatic CMV infection. This study will also gather data on the effectiveness of letermovir to reduce inflammation when compared to no anti-CMV study treatment. In addition, the study will collect …

Learn More

Trial to Evaluate a Modified Vaccine (Triplex ) in Adults with HIV-1 and CMV Who Are on Potent Combination ART with Conserved Immune Function

18 years - 99 years

All genders

Phase 2

Interventional

The purpose of this study is to see if an investigational vaccine for cytomegalovirus (CMV), called Triplex®, is safe when given to people with both Human Immunodeficiency Virus (HIV) and CMV.

Learn More